Coming Soon: One Million Cancer Patients Will Have Personalized Their Treatment Using Oncotype DX Tests

Share this article

One Million Cancer Patients Will Have Personalized Their Treatment Using Oncotype DX Tests

We are excited to share that before the end of the year, we expect one million patients will have benefitted from personalizing their cancer treatment decision with an Oncotype DX test. Since the first Oncotype DX Breast Recurrence Score test was made available in 2004, we have been proud to be a pioneer in transforming the field of precision medicine and making a life-changing impact for cancer patients and their loved ones.

We are grateful to have formed such great partnerships with the cancer advocacy community throughout the years, and plan to build upon this achievement to continue transforming cancer treatment and ensure patients can make a confident, informed decision about their care.

Oncotype DX My Colon Cancer Coach